Breaking News Instant updates and real-time market news.

AMAG

Amag Pharmaceuticals

$18.33

0.04 (0.22%)

04:57
11/06/18
11/06
04:57
11/06/18
04:57

Amag Pharmaceuticals downgraded to Underweight from Neutral at JPMorgan

JPMorgan analyst Jessica Fye downgraded Amag Pharmaceuticals to Underweight and lowered her price target for the shares to $18 from $20. The analyst calls 2019 an investment year for the company.

  • 27

    Nov

  • 23

    Mar

AMAG Amag Pharmaceuticals
$18.33

0.04 (0.22%)

08/02/18
PIPR
08/02/18
NO CHANGE
Target $22
PIPR
Neutral
Piper 'comfortable' on sidelines of Amag given generic Makena risk
Piper Jaffray analyst Christopher Raymond said Amag Pharmaceuticals reported strong results for both Makena and Feraheme along with an "impressive" EBITDA beat in Q2, but he remains comfortable on the sidelines given that multiple Makena generic entrants are expected in the second half of this year. Raymond raised his price target on Amag shares to $22 from $20 but keeps a Neutral rating on the stock.
09/26/18
PIPR
09/26/18
NO CHANGE
PIPR
Neutral
Piper says Amag goal to add 174 patients to trial by 2019 'may be a tall order'
Piper Jaffray analyst Christopher Raymond noted that Amag Pharmaceuticals announced it has taken over development of digoxin immune Fab for the treatment of severe preeclampsia from Velo Bio and seeks to add an additional 174 patients by the end of 2019, which he believes "may be a tall order." As he waits to see how enrollment progresses for this trial, he continues to have concerns with Amag's current franchise as Makena, which makes up over 70% of revenue, recently began facing generic competition, Raymond tells investors. The analyst maintains a Neutral rating on Amag shares and says he is still "comfortable on the sidelines."
11/01/18
PIPR
11/01/18
NO CHANGE
Target $20
PIPR
Neutral
Piper still cautious on Amag after 'bit of a bombshell' guidance
Piper Jaffray analyst Christopher Raymond lowered his price target for Amag Pharmaceuticals to $20 from $22 following the company's "essentially in-line" Q3 results and "surprisingly lower" initial fiscal 2019 guidance, he calls a "bit of a bombshell." The analyst is "flummoxed" by the non-GAAP EBITDA loss guidance of $50M, which he notes represents a $100M negative swing versus consensus. This appears to be driven by investment in Vyleesi, a product "in which we have very little confidence," Raymond tells investors in a post-earnings research note. He remains cautious on Amag shares with a Neutral rating.
11/02/18
PIPR
11/02/18
NO CHANGE
PIPR
Neutral
Amag's Makena supply issues 'more dire than thought,' says Piper Jaffray
Piper Jaffray analyst Christopher Raymond said that Amag Pharmaceuticals made what he would consider material additional disclosures in today's 10-Q filing that he did not hear during the company's earnings call yesterday regarding Makena supply disruptions. The company now states that Makena supply disruptions are expected to result in a stock-out of the multi-dose, 5mL vial "in the near future," which Raymond said is a change from last quarter's filing, which indicated supply limitations were confined to the single-dose, 1mL vial. The company also pointed to the potential for supply issues with Makena's SubQ auto-injector format, though that language "may be out of an abundance of caution," Raymond said. While he is not lowering his estimates, the filing details may indicate potential downside risk to Makena estimates, said the analyst, who keeps a Neutral rating on Amag shares.

TODAY'S FREE FLY STORIES

AROC

Archrock

$10.06

0.365 (3.76%)

20:33
02/19/19
02/19
20:33
02/19/19
20:33
Earnings
Archrock sees FY19 net income $73M-$103M vs. $29.2M in FY18 »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

CTL

CenturyLink

$14.10

0.37 (2.69%)

20:32
02/19/19
02/19
20:32
02/19/19
20:32
Downgrade
CenturyLink rating change  »

CenturyLink downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 11

    Mar

TTD

Trade Desk

$161.76

3.69 (2.33%)

20:31
02/19/19
02/19
20:31
02/19/19
20:31
Downgrade
Trade Desk rating change  »

Trade Desk downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

CVS

CVS Health

$69.92

0.39 (0.56%)

, SO

Southern Company

$48.91

0.35 (0.72%)

20:25
02/19/19
02/19
20:25
02/19/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

CVS

CVS Health

$69.92

0.39 (0.56%)

SO

Southern Company

$48.91

0.35 (0.72%)

ADI

Analog Devices

$104.21

-1.49 (-1.41%)

HSIC

Henry Schein

$63.11

0.73 (1.17%)

OC

Owens Corning

$55.38

0.73 (1.34%)

WIX

Wix.com

$125.70

4.31 (3.55%)

WWW

Wolverine World Wide

$39.50

-0.04 (-0.10%)

CNDT

Conduent

$14.52

0.93 (6.84%)

OMI

Owens & Minor

$7.94

0.25 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 12

    Mar

  • 18

    Mar

  • 19

    Mar

  • 09

    Apr

  • 28

    May

AROC

Archrock

$10.06

0.365 (3.76%)

20:21
02/19/19
02/19
20:21
02/19/19
20:21
Earnings
Archrock reports Q4 EPS 10c, consensus 8c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AI

Arlington Asset Investment

$8.70

-0.14 (-1.58%)

20:09
02/19/19
02/19
20:09
02/19/19
20:09
Syndicate
Arlington Asset Investment 6M share Spot Secondary priced at $8.33 »

Arlington Asset announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

GLD

SPDR Gold Shares

$126.70

1.89 (1.51%)

19:46
02/19/19
02/19
19:46
02/19/19
19:46
Hot Stocks
SPDR Gold Shares holdings fall to 792.45MT from 793.03MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$305.56

-2.2 (-0.71%)

19:17
02/19/19
02/19
19:17
02/19/19
19:17
Hot Stocks
Tesla CEO says company will make about 500,000 cars in 2019 »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 18

    Mar

  • 19

    Mar

IDCC

InterDigital

$73.13

-0.26 (-0.35%)

19:06
02/19/19
02/19
19:06
02/19/19
19:06
Hot Stocks
InterDigital says LG Electronics extends license to use Hillcrest's Freespace »

InterDigital, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

TWTR

Twitter

$31.64

0.41 (1.31%)

19:03
02/19/19
02/19
19:03
02/19/19
19:03
Hot Stocks
Tesla CEO says 4,000 cars loading in San Francisco for Europe »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

OSPN

OneSpan

$16.78

0.645 (4.00%)

, HSTM

HealthStream

$26.95

0.09 (0.34%)

19:01
02/19/19
02/19
19:01
02/19/19
19:01
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

OSPN

OneSpan

$16.78

0.645 (4.00%)

HSTM

HealthStream

$26.95

0.09 (0.34%)

LNTH

Lantheus

$19.18

0.67 (3.62%)

CDNS

Cadence Design

$52.65

0.09 (0.17%)

CRMT

America's Car-Mart

$81.74

-0.43 (-0.52%)

DVN

Devon Energy

$28.31

-0.11 (-0.39%)

LMAT

LeMaitre

$25.09

-0.01 (-0.04%)

FIVN

Five9

$54.31

0.1 (0.18%)

NVTA

Invitae

$16.49

0.43 (2.68%)

LZB

La-Z-Boy

$32.23

0.845 (2.69%)

DK

Delek US

$34.87

0.025 (0.07%)

VRSK

Verisk Analytics

$124.45

-0.93 (-0.74%)

WIRE

Encore Wire

$56.32

1.32 (2.40%)

HLF

Herbalife Nutrition

$57.46

0.8 (1.41%)

TVTY

Tivity Health

$21.67

0.28 (1.31%)

IIN

IntriCon

$29.43

2 (7.29%)

LC

LendingClub

$3.62

0.05 (1.40%)

CXO

Concho Resources

$120.95

-2.03 (-1.65%)

FANG

Diamondback Energy

$104.75

-0.78 (-0.74%)

TXRH

Texas Roadhouse

$65.58

0.03 (0.05%)

SSTI

ShotSpotter

$48.18

2.2 (4.78%)

OMI

Owens & Minor

$7.94

0.25 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 19

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 04

    Mar

  • 11

    Mar

  • 12

    Mar

  • 12

    Mar

  • 13

    Mar

  • 13

    Mar

  • 14

    Mar

  • 18

    Mar

  • 28

    Mar

  • 22

    May

  • 28

    May

HBM

Hudbay Minerals

$6.35

0.365 (6.10%)

18:58
02/19/19
02/19
18:58
02/19/19
18:58
Hot Stocks
Hudbay Minerals announces increased reserves at Lalor mine »

Hudbay Minerals announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

HBM

Hudbay Minerals

$6.35

0.365 (6.10%)

18:56
02/19/19
02/19
18:56
02/19/19
18:56
Hot Stocks
Hudbay Minerals reports Q4 copper output 37.2K tonnes, down 14% from last year »

Reports Q4 gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

CLXT

Calyxt

$13.56

0.15 (1.12%)

18:55
02/19/19
02/19
18:55
02/19/19
18:55
Hot Stocks
Calyxt, Agtegra Cooperative announce strategic collaboration »

Calyxt and Agtegra…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBM

Hudbay Minerals

$6.35

0.365 (6.10%)

18:54
02/19/19
02/19
18:54
02/19/19
18:54
Earnings
Hudbay Minerals reports Q4 EPS (1c), consensus 18c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

NOC

Northrop Grumman

$287.36

0.44 (0.15%)

18:39
02/19/19
02/19
18:39
02/19/19
18:39
Hot Stocks
Northrop Grumman recommends shareholders to reject offer by TRC Capital »

Northrop Grumman has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$277.89

0.49 (0.18%)

18:31
02/19/19
02/19
18:31
02/19/19
18:31
Periodicals
POTUS says U.S. corn sales to China part of trade talks, Bloomberg says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$277.89

0.49 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$9.69

0.11 (1.15%)

18:29
02/19/19
02/19
18:29
02/19/19
18:29
Hot Stocks
Aphria announces early termination of Liberty Health Sciences divestment »

Aphria announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$18.01

0.02 (0.11%)

, AGN

Allergan

$137.94

-1.13 (-0.81%)

18:26
02/19/19
02/19
18:26
02/19/19
18:26
Hot Stocks
Teva finalizes settlement with FTC to resolve all outstanding litigation »

Teva Pharmaceutical…

TEVA

Teva

$18.01

0.02 (0.11%)

AGN

Allergan

$137.94

-1.13 (-0.81%)

ABBV

AbbVie

$80.50

-0.35 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 22

    Feb

  • 25

    Feb

  • 18

    May

  • 28

    May

18:25
02/19/19
02/19
18:25
02/19/19
18:25
Conference/Events
CLSA technology analyst to hold an analyst/industry conference call »

Technology Sales…

VICL

Vical

$1.01

(0.00%)

18:19
02/19/19
02/19
18:19
02/19/19
18:19
Hot Stocks
Breaking Hot Stocks news story on Vical »

Vical resumes trade down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

K

Kellogg

$57.39

0.5847 (1.03%)

, MDLZ

Mondelez

$48.10

-0.07 (-0.15%)

18:19
02/19/19
02/19
18:19
02/19/19
18:19
Periodicals
Kellogg, Mondelez stock up on snacks as Brexit looms, Reuters reports »

With Brexit on the…

K

Kellogg

$57.39

0.5847 (1.03%)

MDLZ

Mondelez

$48.10

-0.07 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 06

    Mar

  • 28

    May

OMI

Owens & Minor

$7.94

0.25 (3.25%)

18:19
02/19/19
02/19
18:19
02/19/19
18:19
Earnings
Owens & Minor guides initial FY19 EPS 60c-75c, consensus $1.02 »

"2019 is about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

OMI

Owens & Minor

$7.94

0.25 (3.25%)

18:17
02/19/19
02/19
18:17
02/19/19
18:17
Earnings
Owens & Minor reports Q4 adjusted EPS 9c, consensus 13c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

USAC

USA Compression

$15.61

0.61 (4.07%)

18:15
02/19/19
02/19
18:15
02/19/19
18:15
Recommendations
USA Compression analyst commentary at MUFG »

USA Compression Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.